Shares in ASX-listed Lumos Diagnostics plunged by more than 60 per cent after the US regulator blocked its flagship product.
Business / Companies
Brisbane Times – Business
Shares in ASX-listed Lumos Diagnostics plunged by more than 60 per cent after the US regulator blocked its flagship product.
Business / Companies
Brisbane Times – Business